НовостиBenzingaTelix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy Benzinga 2026.09.30 13:38 (GMT+0) Открыть на Benzinga Другие новости